{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Vm59CiUMNC\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/20046\/\">Not\u00edcias e notas sobre sa\u00fade animal de 3 de setembro de 2004<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/20046\/embed\/#?secret=Vm59CiUMNC\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for September 3, 2004&#8221; &#8212; Brakke Consulting Website\" data-secret=\"Vm59CiUMNC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for September 3, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* IN THE NEWS: &nbsp; earnings news: Bayer Del Monte Ridley Swift &amp; Co. &nbsp; other news: Agri Laboratories Bioniche Life Sciences Bommeli Cargill Central Garden Cross Vetpharm Energy Savers Unlimited Frontier Beef Systems GenVec IDEXX Intervet Merial Pfizer Seara Alimentos Tridelta Tyson &nbsp; &nbsp; ****************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Bayer reported results for the second quarter and first half of 2004.&nbsp; Sales for its Animal Health division were 225 million euros ($272 million), an increase of 5% compared to the second quarter of 2003, due largely to stronger demand in North America.&nbsp; Sales increased 9% in local currencies.&nbsp; Advantix and Baycox continued to perform well.&nbsp; For the first half of 2004, Animal Health sales were 403 million euros ($487 million), an increase of 2.5% compared to the first half of 2003.&nbsp; (company website)&nbsp; &nbsp; &gt;&nbsp; Ridley Inc. reported results for its fiscal 2004 year and fourth quarter ended June 30, 2004.&nbsp; Sales revenues for the year declined by 8.2% in fiscal 2004 to C$610 million (US$454 million) from C$665 million (US$494 million) in fiscal 2003. Feed sales volumes decreased in fiscal 2004 by 8.1% overall. Net earnings for fiscal 2004 were C$10.9 million (US$8.1 million), compared with C$10.4View Full Post;"}